baber/WOPTO huggingface dataset:
Patent AU-6363296-A (AU)
Title: CB2 receptor agonist compounds
Inventor: RINALDI MURIELLE
IPC: C07D209/08
Filed: 1996-06-20
Abstract: The use of human CB2 receptor-specific agonists of formula (I) or (I') for preparing immunomodulating drugs is disclosed. In formulae (I) and (I'), R1 is a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11, -CHR9CH2NR'6R'11, -(CH2)nZ and -COR8; R'1 is a -CH2CHR10NR6R11 or -(CH2)2NR'6R'11 group; R2 and R'2 are hydrogen, halogen or C1-4 alkyl; R3 is hydrogen, C1-4 alkyl or a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11 and -COR8; R'3 is a =CR6R8 group; R4 has one of the meanings given for R5 or is a -COR8 group; R5 is hydrogen, C1-4 alkyl, C1-4 alkoxy, a halogen atom, a CF3 group, an OCF3 group or C1-4 alkylthio; R'5 has one of the meanings given for R5 and is in the 5 or 6 position of the indene ring; R6 is hydrogen or C1-4 alkyl; R'6 is C1-4 alkyl; R7 has one of the meanings given for R5 or R7 and R9 together form a -Y-CH2- group attached to the indole ring in the 7 position by a group Y; R8 is phenyl substituted one to four times by a substituent selected from halogen, C1-4 alkyl or C1-4 alkoxy; a polycyclic ring selected from naphth-1-yl, naphth-2-yl, 1,2,3,4-tetrahydronaphth-1-yl, 1,2,3,4-tetrahydronaphth-5-yl, anthryl, benzofuryl, benzothien-2-yl, benzothien-3-yl, 2-, 3-, 4- or 8-quinolyl, said polycyclic rings optionally being substituted once or twice by a substituent selected from C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halogen, cyano, hydroxyl, trifluoromethyl and imidazol-1-yl; R10 and R11 together are a group selected from -CH2-O-CH2-CR12R13- and -(CH2)p-CR12R13-, wherein the carbon atom substituted by R12 and R13 is attached to the nitrogen atom; R'11 is C1-4 alkyl; or R'11 and R'6, taken together with the nitrogen atom to which they are attached, form a group selected from morpholin-4-yl, thiomorpholin-4-yl, piperidin-1-yl and pyrrolidin-1-yl; each of R12 and R13 is independently hydrogen or C1-4 alkyl; n is 2, 3, 4 or 5; p is 2 or 3; Z is a methyl group or a halogen atom; and Y is a methylene group or an oxygen atom.
Patent AU-6445990-A (AU)
Title: Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
Inventor: FRIDEN PHILLIP
IPC: A61K47/48
Filed: 1990-09-07
Abstract: The present invention pertains to a method for delivering a neuropharmaceutical agent across the blood brain barrier to the brain of a host. The method comprises administering to the host a therapeutically effective amount of an antibody-neuropharmaceutical agent conjugate wherein the antibody is reactive with a transferrin receptor. Other aspects of this invention include a delivery system comprising an antibody reactive with a transferrin receptor linked to a neuropharmaceutical agent and method for treating hosts afflicted with a disease associated with a neurological disorder.
Patent AU-6474786-A (AU)
Title: Fast response tubeless vacuum aspiration collection cassette
Inventor: SUNDBLOM LEIF J
IPC: A61M1/00
Filed: 1986-09-24
Abstract: A fast response, tubeless vacuum aspiration collection cassette includes large and small containers (30, 31) defined within a cassette housing adapted to be removably secured to a surgical aspiration machine. A first wall of the cassette housing abutting the machine includes connectors (58 and 68, 71) thereto to provide a controlled variable vacuum level to the small container (30), and a fixed vacuum level to the large container (31). The channels (47, 57, 42, 44 and 42, 61, 66) and valves (43, 46 and 62) are arranged so that when the containers (30, 31) are isolated by a first valve (62), the controlled vacuum level may be applied to the surgical probe through a second valve (43, 46) connecting it to the small container volume (30). Whenever the controlled vacuum is shut off to the probe by the second valve (43, 46) the first valve (62) is opened to permit the fixed vacuum in the larger container (31) to be applied to the smaller container (30) to transfer aspirant fluid therein to the larger container (31).
Patent AU-6489986-A (AU)
Title: Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
Inventor: KIT MALON
IPC: C12N15/09
Filed: 1986-11-05
Abstract: Bovine herpesvirus type 1 (infectious bovine rhinotracheitis virus) mutants which fail to produce any functional thymidine kinase as a result of a deletion in the thymidine kinase gene. The deletion in the thymidine kinase gene attenuates the viruses so that they can be used as an active agent in a modified live-virus vaccine against infectious bovine rhinotracheitis. This invention also relates to methods for the production and use of the same.
Patent AU-6522280-A (AU)
Title: Quinone dispersions
Inventor: BAUER D
IPC: D21C9/10
Filed: 1980-12-10
Abstract: For the Contracting States : BE, DE, FR, GB, IT, SE 1. Dispersions of dinitroanthraquinones for use in processes for the production of pulp, characterized in that they contain the dinitroanthraquinones, in finely divided form, surface-active agents and water and/or liquid organic compounds with boiling points above 80 degrees C. For the Contracting State : AT 1. Process for the preparation of dispersions of dinitroanthraquinones for use in processes for the production of pulp, characterized in that dinitroanthraquinones, surface-active agents and water and/or liquid organic water-miscible compounds with boiling points above 80 degrees C are group with one another.
Patent AU-6544199-A (AU)
Title: Process for the preparation of a maltose-rich syrup
Inventor: CABOCHE JEAN-JACQUES
IPC: C12P7/18
Filed: 1999-12-22
Abstract: A process for the manufacture of a maltose rich syrup is new and comprises liquefying and saccharifying a starch milk in the presence of  beta -amylase and at lest one debranching enzyme e.g. pullulanases and/or isoamylases, filtering the solution and recovering the maltose and glucose enriched fractions and contacting the maltose rich solution with a maltogenic  alpha -amylase to obtain the maltose rich syrup.  Independent claims are also included for the following:  (1) manufacture of a maltose rich syrup comprising:  (a) liquefaction of a starch milk;  (b) saccharification of the starch milk in the presence of a  beta -amylase;  (c) filtering the starch milk to recover maltose and glucose and maltose enriched fractions; (d) contacting the maltose rich fraction with a maltogenic  alpha -amylase and at least one debranching enzyme e.g. pullulanases and/or isoamylases for obtaining the maltose rich syrup; and  (2) the manufacture of crystallized maltose comprising crystallizing maltose rich syrup.
Patent AU-6691794-A (AU)
Title: Processes for chromatographic fractionation of fatty acids and their derivatives
Inventor: PERRUT MICHEL
IPC: C11B7/00
Filed: 1994-04-29
Abstract: PCT No. PCT/NO94/00079 Sec. 371 Date Jan. 18, 1996 Sec. 102(e) Date Jan. 18, 1996 PCT Filed Apr. 29, 1994 PCT Pub. No. WO94/25552 PCT Pub. Date Nov. 10, 1994A process for recovering at least one of purified polyunsaturated fatty acids (PUFA) and polyunsaturated fatty acid mixtures from a feed composition includes a step of (i) treating the composition by either (a) stationary bed chromatography or (b) multistage countercurrent column fractionation in which a solvent is a fluid at supercritical pressure, and recovering at least one PUFA-enriched fraction. The process also includes a step of (ii) subjecting the fraction recovered in the treating step to further fractionation by simulated continuous countercurrent moving bed chromatography, and recovering at least one fraction containing the purified PUFA or the PUFA mixture.
Patent AU-6737687-A (AU)
Title: A method and a circuit for decoding four-channel signals which are coded in a matrix and available in the form of a two-channel signal
Inventor: SPARKJAER OLE
IPC: H04S3/00
Filed: 1986-12-04
Abstract: PCT No. PCT/DK86/00131 Sec. 371 Date Aug. 4, 1987 Sec. 102(e) Date Aug. 4, 1987 PCT Filed Dec. 4, 1986 PCT Pub. No. WO87/03771 PCT Pub. Date Jun. 18, 1987.By a method and a circuit for the purpose of decoding four-channel signals coded in a matrix and available in the form of a two-channel signal, whereby in each channel an automatic control of the amplification will take place by means of an output amplifier ( DELTA L,  DELTA R,  DELTA B,  DELTA C) in the output stage in question, it is proposed that the differential signal is conducted both to a delay circuit ( DELTA T) and then to an expander circuit (EXP), and also to a central rectifier element (D1), that the output signal (UCD) form the rectifier circuit (D1, CA, CD) is both conducted to the expander circuit (EXP) and applied for controlling the channels in pairs, whereby the stereo channels are controlled in phase and the center and background channels in reversed phase of the mean value (UCD) of the differential signal, and that all channels moreover adjusted both in phase to the DC component of the summation signal amplitude and also in accordance with a level chosen in advance.
Patent AU-6886391-A (AU)
Title: Pyrazolines for the protection of crops against herbicides
Inventor: ROSCH WOLFGANG
IPC: A01P13/00
Filed: 1990-11-26
Abstract: Compounds of the formula (I)   <IMAGE>   where X, n, R1, R2 and R3 are as defined in claim 1 are suitable as antidotes against phytotoxic secondary effects of herbicides in crop plants without adversely affecting the action of the herbicides against harmful plants.
Patent AU-6938094-A (AU)
Title: Oxidoreductase from filamentous fungi, dna coding therefor and cells transformed with said dna
Inventor: BRINK JOHANNES MAARTEN VAN DEN
IPC: C12N15/09
Filed: 1994-06-10
Abstract: PCT No. PCT/NL94/00135 Sec. 371 Date Nov. 28, 1995 Sec. 102(e) Date Nov. 28, 1995 PCT Filed Jun. 10, 1994 PCT Pub. No. WO94/29453 PCT Pub. Date Dec. 22, 1994Disclosed is a new gene which codes for a NADPH cytochrome P450 oxidoreductase from filamentous fungi. Also disclosed are a recombinant DNA molecule which comprises at least a part of that gene, an RNA molecule derived therefrom and a new polypeptide (or protein), as well as at least one host cell transformed with such recombinant DNA molecule. Particularly suitable host cells are those originating from a filamentous fungus. With the polypeptides (proteins) and the host cells according to the invention, new processes for enzymatic conversions can be performed. In particular, enzymatic conversions by means of monooxygenases, more particularly by means of enzymes from the cytochrome P450 superfamily are improved with the invention.
Patent AU-7125494-A (AU)
Title: Base station with time-aligned mobile transmitting moments according to distance to base station
Inventor: SUONVIERI JUKKA
IPC: H04J3/06
Filed: 1994-06-29
Abstract: PCT No. PCT/FI94/00298 Sec. 371 Date Jan. 5, 1996 Sec. 102(e) Date Jan. 5, 1996 PCT Filed Jun. 29, 1994 PCT Pub. No. WO95/02306 PCT Pub. Date Jan. 19, 1995For increasing the radius of the effective service area of a base station in a digital time division multiple access (TDMA) radio network, a first transceiver is provided for communicating with mobile radio stations only within a radially outer annular region, and a second transceiver is provided for communicating with the mobile radio stations within a central region a radially outer marginal portion of which overlaps with a radially inner marginal portion of the outer annular region. Timing offsets between transmissions from the base station transceivers and transmissions from the mobile stations being such that respective transmissions are received within proper time slots despite that the outer radius of radially outer annular region would necessitate a larger than workable time delay were the first transceiver used by itself for serving the entire radial extent of the respective composite effective coverage areas of the first and second transceivers.
Patent AU-7132891-A (AU)
Title: Low phospholipid oil extraction process
IPC: A23D7/00
Filed: 1991-02-22
Abstract: A vegetable oil process and assembly is disclosed for extracting oil from an oil bearing material such as soybean, corn and the like. The process comprises adding at least one reagent and an oil of preferably the same type as will be extracted from the oil bearing material to the oil bearing material to form a slurry mixture. The slurry is heated at a preselected temperature for a preselected period of time preferably under a partial vacuum. This processing reduces the phospholipid and trace metal content in the oil extracted from the oil bearing material. The oil product produced is light in color, shows no turbidity and exhibits a minimal amount of phosphorus, calcium, magnesium and iron. The oil is ready for physical refining.
Patent AU-7170087-A (AU)
Title: Barking apparatus
Inventor: ERIKSSON KJELL-ANDERS
IPC: B27L/
Filed: 1987-03-25
Abstract: PCT No. PCT/SE87/00154 Sec. 371 Date Sep. 27, 1988 Sec. 102(e) Date Sep. 27, 1988 PCT Filed Mar. 25, 1987 PCT Pub. No. WO87/05851 PCT Pub. Date Oct. 8, 1987.A barking method, and an apparatus for utilization of the method, wherein a log (6) during a substantially linear feeding movement is brought to pass one or a number of barking devices (1; 4,4'), arranged to perform a surrounding rotary movement in relation to the log (6), the barking devices (1; 4, 4') are pressed into a contact position against the log by centrifugal force during the surrounding rotary movement in relation to the log, and the contact pressure of the barking devices (1; 4, 4') is continuously variable by increasing/decreasing the rotary speed of the barking devices (1; 4, 4') and the cutters are arranged inclined at an angle in relation to the feed direction of the log (6), to produce a feeding movement for the log (6) in a direction through the barking device (1; 4, 4').
Patent AU-7218001-A (AU)
Title: Non-toxic primer mix
Inventor: JOHN HENRY J JR
IPC: C06C7/00
Filed: 2001-09-18
Abstract: A non-toxic primer mix including both bismuth sulfide and potassium nitrate as the pyrotechnic portion of the primer is disclosed. In a further embodiment, a non-toxic primer mix comprising zinc sulfide and aluminium nitrate as the pyrotechnic portion of the primer mix is disclosed. Bismuth and zinc sulfide act as fuels for the oxidizers of potassium and aluminum nitrate in providing an ignition flame for the primer. The non-toxic primer mix further contains a lead-free explosive material, and additionally can include added fuels, sensitizers, explosives and binders.
Patent AU-7264294-A (AU)
Title: Arrangement for cooling supply air in an air-conditioning installation
Inventor: KANNINEN SEPPO KALEVI
IPC: F24F12/00
Filed: 1994-08-09
Abstract: PCT No. PCT/FI94/00342 Sec. 371 Date Apr. 19, 1996 Sec. 102(e) Date Apr. 19, 1996 PCT Filed Aug. 9, 1994 PCT Pub. No. WO95/04902 PCT Pub. Date Feb. 16, 1995The invention relates to an arrangement for cooling supply air in an air-conditioning installation, comprising a heat transfer device for transferring heat between supply air and exhaust air by means of heat transfer surfaces; and a humidifying device for humidifying heat transfer surfaces on the exhaust air side. In order that supply air could be cooled more efficiently, the heat transfer surfaces on the side of supply air and exhaust air are separated into separate heat exchangers; and the heat transfer surfaces are selected in such a way that the surface temperature of the heat transfer surfaces on the exhaust air side is close to the dew-point temperature of exhaust air.
Patent AU-7292094-A (AU)
Title: Cartridge-needle unit having retractable needle
Inventor: JOHNSON KEVIN M
IPC: A61M5/50
Filed: 1994-09-12
Abstract: This invention relates to a novel cartridge-needle unit having a retractable needle for use with disposable or reusable holders to form safety syringes.The cartridge-needle unit comprises a cartridge (10) comprising a hollow body (14), a septum (18) at the distal end of the body (14), means (16) for retaining the septum (18), and a plunger (20), axially and reciprocally slidable through the interior of the body (14); a needle (22) capable of being retracted within the cartridge (10); a hub (24) comprising a sleeve (26) adapted to be snapped on the distal end of the cartridge (10); means (28,30,32) for retaining the needle (22) within the hub (24) during an injection; and means (28,30) for releasing the needle (22) from the hub (24) after the injection comprising an element (30) attached to the needle (22), and having a diameter greater than said needle, capable of passing through the septum (18).The retractable cartridge-needle unit exhibits improved reliability, reduces the tendency for body fluids and/or medication to remain in an unprotected area upon retraction of the needle and virtually eliminates the possibility that the needle can be released into the patient.
Patent AU-7330694-A (AU)
Title: Granular laundry detergent compositions containing stabilised percarbonate bleach particles
Inventor: BAILLELY GERARD MARCEL
IPC: C11D3/12
Filed: 1994-07-13
Abstract: There is provided a granular, silicate-built, phosphate free laundry detergent composition comprising fine alkali metal percarbonate particles having mean particle diameter below 450  mu m, preferably below 400  mu m, wherein no more than 20%, preferably no more than 10%, of the particles have a diameter above 710  mu m, said particles having a coating comprising one or more soluble inorganic salts. The salts may be selected from alkali or alkaline earth metal carbonates, sulphates, chlorides and nitrates. The coated percarbonate particles have improved stability to storage and are capable of dissolving quickly in wash liquor.
Patent AU-7465681-A (AU)
Title: Serum-derived leukorecruitin
Inventor: WISSLER JOSEF H
IPC: B01D15/04
Filed: 1981-08-26
Abstract: The invention relates to SERUM-DERIVED "LEUKORECRUITIN", which is A PROTEIN MEDIATOR OF INFLAMMATION FROM MAMMALIAN SERUM specifically inducing positive leukocytosis reaction and leukocyte recruitment from the bone marrow into the blood of animals and humans without biological side-reactions. The process for the production and isolation of leukorecruitin is characterized in that mammalian serum is subjected to regulated and limited proteolysis by contact activation, the protein is then separated from other foreign constituents and proteins of serum in the form of a crude serum protein concentrate fraction, and/or the protein is separated from other serum-proteins by chromatography on hydroxyapatite. Leukorecruitin has very valuable pharmacological effects and can be used in compositions for specifically influencing the defense state of the animal or human body and for diagnostic purposes in hematological disorders.
Patent AU-7494396-A (AU)
Title: Roller skate with brake
Inventor: OPERCAN JOHANN
IPC: A63C17/14
Filed: 1996-10-28
Abstract: The novelty of the braking system is that the brakes (which are mounted in the boot) are operated by the toes. Fitted inside the boot tip is a pedal which is pressed downwards by the toes. In addition, levers urge the brake members onto the rollers from above such that the rollers are braked. The braking force on the front rollers is metered to ensure manoeuvrability during the braking process.
Patent AU-7510900-A (AU)
Title: Novel chalcones
Inventor: BOMBARDELLI EZIO
IPC: C07D409/06
Filed: 2000-08-28
Abstract: Disclosed are novel chalcone derivatives having the formula (I)The compounds possess antiproliferative activity and are useful for the manufacture of a medicament for the treatment or prevention of neoplasms, particularly those located in the uterus, ovary or breast. The compounds of the invention may also be useful in the manufacture of a medicament for the treatment or prevention of menopausal disorders and osteoporosis.
Patent AU-7585498-A (AU)
Title: Inhibition of p38 kinase activity by aryl ureas
Inventor: RANGES GERALD
IPC: A61P1/02
Filed: 1998-05-21
Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
Patent AU-7663600-A (AU)
Title: Covered stent and method of making it
Inventor: SOLEM JAN OTTO
IPC: A61F2/852
Filed: 2000-10-05
Abstract: A method of making a covered stent comprises the steps of producing a stent (1) having a diameter corresponding to an unexpanded state of the stent (1) and producing a tube (2) of a film material. The film material of the tube (2) should be shrinkable by exposure to an elevated temperature and the tube (2) should, before shrinking, have a greater diameter than the stent (1). As further steps of the method, the stent (1) is introduced into the tube (2), and the tube (2) is exposed to the elevated temperature for reducing the diameter of the tube (2) such that the stent (1) is affixed within the tube (2). The tube may be longer than the stent such that the ends of the tube may be introduced into the ends of the stent and affixed by short sections of a stent material. Collars may be formed at the ends of the tube and may also be covered by the film material.
Patent AU-7695100-A (AU)
Title: Vaccine
Inventor: ANTONSSON PER
IPC: A61P35/00
Filed: 2000-09-19
Abstract: The invention relates to a carrier for introduction of a substance into cells, comprising a major capsid protein L1 of human papillomavirus (HPV-L1 protein) which has been intentionally modified to remove type-specific epitope(s) causing production of neutralising antibodies. The invention also includes an oligo- or polynucleotide coding for said carrier, vaccines comprising said carrier or said oligo- or polynucleotide, as well as methods of using the carrier or the oligo- or polynucleotide in vaccination against infections of human papillomavirus, or against development of consequences of such an infection, or against development of certain cancers.
Patent AU-7695494-A (AU)
Title: Natural triglyceride fats
Inventor: SASSEN CARLO L
IPC: A23D7/00
Filed: 1994-09-08
Abstract: Glyceride fat which comprises a mixture of glycerides originating from seed oilswhich have not substantially been subjected to chemical modification,which glycerides are derived from fatty acids which comprise(a) at least 10 wt. % of C18-C24 saturated fatty acids(b) which comprise stearic and/or arachidic and/or behenic acid and/or lignoceric acid(c) oleic and/or linoleic acid, while(d) the ratio of saturated C18-acid/saturated (C20+C22+C24)-acids >=1, preferably >=5, more preferably >=10,which glycerides contain calculated on total fatty acid weight(e) <=5 wt. % of linolenic acid(f) <=5 wt. % of trans fatty acids(g) <=75 wt. %, preferably <=60 wt. % of oleic acid on total fatty acids on position 2 of the glyceride moleculewhich glycerides contain calculated on total glycerides weight(h) >=8 wt. % HOH+HHO triglycerides(i) <=5 wt. % of trisaturated triglycerides(j) which glycerides have a solids content comprising N10>10 and N35<=15and which is characterised in that the ratio of (HOH+HHO) and (HLH+HHL) triglycerides >1, where H is a saturated C18-C24 fatty acid residue, O is an oleic acid residue and L is a linoleic acid residue.
Patent AU-8275887-A (AU)
Title: Barrier products
Inventor: TALLENTIRE ALAN
IPC: B01D39/14
Filed: 1987-11-20
Abstract: A porous material (e.g. a paper 6) has pores with a range of sizes. A pore modifying agent (comprising particles 8 of a narrow size range) is selectively incorporated within the larger pores (7) to provide zones (9) of high surface area. These greatly reduce the penetrability of the material (e.g. by micro-organisms) while having relatively little effect on its air-permeability. The modifying agent (8) may be incorporated by creating a pressure difference across the material (2), and treating it with a dispersion (e.g. an aerosol) of the modifying agent (8), under conditions of low inertia, and incorporating only a small amount of the agent (8) (e.g. under 1% w/w).